Biocombination No. 22

BIOPLASGEN/BIOCOMBINATION 22

Indications: Both dry and suppurating scrofulous abscesses. Almost all symptoms of the disease are covered.

Scrofulosis (Scrofula) is a morbid constitutional state of system characterised by indolent glandular tumours that suppurate slowly, heal with difficulty and leave scars.

A well defined skin condition of subcutaneous nodules which gradually enlarge, degenerate, ulcerate and terminate cutaneously. Scrofula as a typical scar tissue is known as Scrofuloderma, lesions commonly occurring about the face, neck through lymph glands. These conditions are also covered by this medicine.

Composition: Calcarea phosphorica 3x, Ferrum phosphoricum 3x, Kalium muriaticum 3x, Silicea 6x in equal proportion.

Proven indications of the ingredients within the claimed sphere of action:

Calcarea phosphorica: Itis indicated for scrophulosis, chlorosis and phthisis covering tubercular glandular enlargements.

Ferrum phosphoricum: Ithas been used in acute exacerbation of tuberculosis, inflammed throat, ulcerated sore throat and restlessness with fever.

Kalium muriaticum: Itis indicated for enlargement of tonsils, lymph glands, sore throat, follicular tonsillitis, vesicles and bursitis. Along with Calcarea phosphorica is covers disturbing symptoms of scrophulosis.

Silicea: Itis used for scrofulous children. It controls abscesses, organic changes and suppurative processes.

Contra-indication: Nil. Dosage: Adults 4 tablets, children 2 tablets, at a time, four times a day at intervals of three hours. Presentation: Tablets of 100 mg. in bottles of 20g.